Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Survival of HIV-positive individuals with hepatitis B and C infection in Michigan.

Butt ZA, Wilkins MJ, Hamilton E, Todem D, Gardiner JC, Saeed M.

Epidemiol Infect. 2014 Oct;142(10):2131-9. doi: 10.1017/S0950268813003038. Epub 2013 Nov 29.

PMID:
24286128
2.

Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.

Sarkar M, Bacchetti P, French AL, Tien P, Glesby MJ, Nowicki M, Plankey M, Gange S, Sharp G, Minkoff H, Peters MG; Women's Interagency HIV Study (WIHS).

Hepatology. 2012 Nov;56(5):1699-705. doi: 10.1002/hep.25859. Epub 2012 Aug 27.

3.

Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan.

Butt ZA, Wilkins MJ, Hamilton E, Todem D, Gardiner JC, Saeed M.

Epidemiol Infect. 2013 Dec;141(12):2604-11. doi: 10.1017/S0950268813000538. Epub 2013 Mar 12.

PMID:
23481310
4.

Bias in online recruitment and retention of racial and ethnic minority men who have sex with men.

Sullivan PS, Khosropour CM, Luisi N, Amsden M, Coggia T, Wingood GM, DiClemente RJ.

J Med Internet Res. 2011 May 13;13(2):e38. doi: 10.2196/jmir.1797.

5.

Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems.

Fuster D, Cheng DM, Quinn EK, Nunes D, Saitz R, Samet JH, Tsui JI.

Addiction. 2014 Jan;109(1):62-70. doi: 10.1111/add.12367. Epub 2013 Oct 24.

6.

Hepatitis B prevalence and influence on HIV treatment outcome and mortality in the Chilean AIDS Cohort.

Otto-Knapp R, Cortes CP, Saavedra F, Wolff M, Weitzel T.

Int J Infect Dis. 2013 Oct;17(10):e919-24. doi: 10.1016/j.ijid.2013.05.009. Epub 2013 Jul 9.

7.

Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.

Mohsen AH, Murad S, Easterbrook PJ.

HIV Med. 2005 May;6(3):206-15.

10.

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; EuroSIDA in EuroCoord.

J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005. Epub 2013 Apr 11.

PMID:
23583272
11.

Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.

van der Helm J, Geskus R, Sabin C, Meyer L, Del Amo J, Chêne G, Dorrucci M, Muga R, Porter K, Prins M; CASCADE Collaboration in EuroCoord.

Gastroenterology. 2013 Apr;144(4):751-760.e2. doi: 10.1053/j.gastro.2012.12.026. Epub 2012 Dec 22.

PMID:
23266560
12.

Spatial epidemiology of HIV-hepatitis co-infection in the State of Michigan: a cohort study.

Butt Z, Grady S, Wilkins M, Hamilton E, Todem D, Gardiner J, Saeed M.

Infect Dis (Lond). 2015;47(12):852-61. doi: 10.3109/23744235.2015.1066931. Epub 2015 Jul 16.

PMID:
26179757
13.

Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004.

Espinoza L, Hall HI, Hardnett F, Selik RM, Ling Q, Lee LM.

Am J Public Health. 2007 Jan;97(1):144-9. Epub 2006 Nov 30.

14.

Explaining racial disparities in HIV incidence in black and white men who have sex with men in Atlanta, GA: a prospective observational cohort study.

Sullivan PS, Rosenberg ES, Sanchez TH, Kelley CF, Luisi N, Cooper HL, Diclemente RJ, Wingood GM, Frew PM, Salazar LF, Del Rio C, Mulligan MJ, Peterson JL.

Ann Epidemiol. 2015 Jun;25(6):445-54. doi: 10.1016/j.annepidem.2015.03.006. Epub 2015 Mar 24.

15.

Characteristics and risk of syphilis diagnosis among HIV-infected male cohort: a population-based study in Houston, Texas.

Yang B, Hallmark CJ, Huang JS, Wolverton ML, McNeese-Ward M, Arafat RR.

Sex Transm Dis. 2013 Dec;40(12):957-63. doi: 10.1097/OLQ.0000000000000056.

PMID:
24220358
16.

All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection.

Hernando V, Perez-Cachafeiro S, Lewden C, Gonzalez J, Segura F, Oteo JA, Rubio R, Dalmau D, Moreno S, Amo JD; CoRIS.

J Hepatol. 2012 Oct;57(4):743-51. doi: 10.1016/j.jhep.2012.06.010. Epub 2012 Jun 16.

PMID:
22709620
17.

[AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].

Zucchetto A, Bruzzone S, De Paoli A, Regine V, Pappagallo M, Dal Maso L, Serraino D, Rezza G, Suligoi B.

Epidemiol Prev. 2009 Jul-Oct;33(4-5):184-9. Italian.

18.

The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.

Matser A, Urbanus A, Geskus R, Kretzschmar M, Xiridou M, Buster M, Coutinho R, Prins M.

Addiction. 2012 Mar;107(3):614-23. doi: 10.1111/j.1360-0443.2011.03654.x.

PMID:
21919987
20.

Racial-ethnic differences in all-cause and HIV mortality, Florida, 2000-2011.

Trepka MJ, Fennie KP, Sheehan DM, Niyonsenga T, Lieb S, Maddox LM.

Ann Epidemiol. 2016 Mar;26(3):176-82.e1. doi: 10.1016/j.annepidem.2016.02.002. Epub 2016 Feb 16.

Supplemental Content

Support Center